Search results
Results From The WOW.Com Content Network
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.
The Financial News Network (FNN) was an American financial and business news television network launched on November 30, 1981. The network aimed to broadcast programming nationwide, five days a week, for seven hours a day on thirteen stations, in an effort to expand the availability of business news for public dissemination.
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and ...
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
In September 2012, Syngenta placed a bid of 403 million euros ($522 million) for the acquisition of Devgen as part of a wave of large ag companies buying biotech companies. [ 22 ] [ 23 ] The offer came six months after the companies had signed an agreement under which Syngenta would have developed sprayable RNAi-based crop protection products ...
For premium support please call: 800-290-4726 more ways to reach us
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer.